Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / SPON1

SPON1

Basics

Aliases:
This biomarker is also known as:
  • Spondin-1,
  • MGC10724,
  • spondin 1, extracellular matrix protein,
  • KIAA0762,
  • spondin 1, (f-spondin) extracellular matrix protein,
  • Vascular smooth muscle cell growth-promoting factor,
  • F-spondin,
  • VSGP,
  • f-spondin,

View in BioMuta

Description…

SPON1, an extracellular matrix protein, is a cell adhesion protein that promotes the attachment of spinal cord and sensory neuron cells and the outgrowth of neurites in vitro. It may contribute to the growth and guidance of axons in both the spinal cord and the PNS. It is a major factor for vascular smooth muscle cell. SPON1 is most highly expressed in lung, lower expression in brain, heart, kidney, liver and testis, and expressed at lowest rate in pancreas, skeletal muscle and ovary. It is not expressed in spleen.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: SPON1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.